AAAAAA

   
Results: 1-9 |
Results: 9
Expression of sodium pump isoforms and other sodium or calcium ion transporters in the heart of hypertensive patients
Authors: Jager, H Wozniak, G Akinturk, IH Hehrlein, FW Scheiner-Bobis, G
Citation: H. Jager et al., Expression of sodium pump isoforms and other sodium or calcium ion transporters in the heart of hypertensive patients, BBA-BIOMEMB, 1513(2), 2001, pp. 149-159
The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high riskfor this disease
Authors: Gardemann, A Lohre, J Katz, N Tillmanns, H Hehrlein, FW Haberbosch, W
Citation: A. Gardemann et al., The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high riskfor this disease, THROMB HAEM, 82(3), 1999, pp. 1121-1126
The factor II G20210A and factor V G1691A gene transitions and coronary heart disease
Authors: Gardemann, A Arsic, T Katz, N Tillmanns, H Hehrlein, FW Haberbosch, W
Citation: A. Gardemann et al., The factor II G20210A and factor V G1691A gene transitions and coronary heart disease, THROMB HAEM, 81(2), 1999, pp. 208-213
Topical treatment of venous ulcer with fibrin stabilizing factor: experimental investigation of effects on vascular permeability
Authors: Wozniak, G Noll, T Brunner, U Hehrlein, FW
Citation: G. Wozniak et al., Topical treatment of venous ulcer with fibrin stabilizing factor: experimental investigation of effects on vascular permeability, VASA, 28(3), 1999, pp. 160-163
The TT genotype of the methylenetetrahydrofolate reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease
Authors: Gardemann, A Weidemann, H Philipp, M Katz, N Tillmanns, H Hehrlein, FW Haberbosch, W
Citation: A. Gardemann et al., The TT genotype of the methylenetetrahydrofolate reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease, EUR HEART J, 20(8), 1999, pp. 584-592
Factor XIII: experimental and clinical results in treatment of patients with diabetic foot ulcer
Authors: Wozniak, G Noll, T Bott, U Hehrlein, FW
Citation: G. Wozniak et al., Factor XIII: experimental and clinical results in treatment of patients with diabetic foot ulcer, ZBL CHIR, 124, 1999, pp. 73-77
Effect of factor XIII on endothelial barrier function
Authors: Noll, T Wozniak, G McCarson, K Hajimohammad, A Metzner, HJ Inserte, J Kummer, W Hehrlein, FW Piper, HM
Citation: T. Noll et al., Effect of factor XIII on endothelial barrier function, J EXP MED, 189(9), 1999, pp. 1373-1382
Angiotensinogen T174M and M235T gene polymorphisms are associated with theextent of coronary atherosclerosis
Authors: Gardemann, A Stricker, J Humme, J Nguyen, QD Katz, N Philipp, M Tillmanns, H Hehrlein, FW Haberbosch, W
Citation: A. Gardemann et al., Angiotensinogen T174M and M235T gene polymorphisms are associated with theextent of coronary atherosclerosis, ATHEROSCLER, 145(2), 1999, pp. 309-314
Association of the insertion/deletion gene polymorphism of the apolipoprotein B signal peptide with myocardial infarction
Authors: Gardemann, A Ohly, D Fink, M Katz, N Tillmanns, H Hehrlein, FW Haberbosch, W
Citation: A. Gardemann et al., Association of the insertion/deletion gene polymorphism of the apolipoprotein B signal peptide with myocardial infarction, ATHEROSCLER, 141(1), 1998, pp. 167-175
Risultati: 1-9 |